BioSpace News Archive

30 January 2024: Special focus on advancements, trends, disruption and enabling technologies that increase robustness and decrease production costs

Corbus Pharmaceuticals Holdings, Inc., a precision oncology company with a diversified portfolio, announced that it plans to offer and sell shares of its common stock or, in lieu of common stock to certain investors, pre-funded warrants to purchase shares of its common stock in an underwritten registered public offering.

Vaxcyte, Inc., a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, announced the pricing of an underwritten public offering of common stock and pre-funded warrants.

PolTREG S.A. announced that Prof. Piotr Trzonkowski, CEO, has co-authored a peer-reviewed article in Frontiers in Immunology, the world’s fifth most-cited immunology journal, laying out the decades of scientific progress underlying the company’s portfolio of ground-breaking clinical-stage therapies for diseases such as Type-1 Diabetes and Multiple Sclerosis.

Qubit Pharmaceuticals and Institut Curie announce their collaboration in the search for new therapeutic avenues to treat cancer.

MorphoSys AG reported preliminary Monjuvi ® U.S. net product sales and gross margin for Monjuvi U.S. net product sales for the full year of 2023 and provides its 2024 financial guidance.

EicOsis Human Health announced the next step in its ongoing human clinical trials: the initiation of Phase 1b multiple-ascending dose clinical trial to test the safety of its drug candidate, EC5026.

Life has a challenging tempo. Sometimes, it moves faster or slower than we’d like. Nevertheless, we adapt. We pick up the rhythm of conversations.

Delta-Fly Pharma Inc.: Update on the Interim Analysis Status of Phase III Study of DFP-10917 in the patients with R/R AML.

ICON plc announced that it will release its financial results for the fourth quarter and full year 2023 results after the market closes on Wednesday, February 21, 2024.